A Lentiviral Vector-Based Gene Therapy Product for the Treatment of Wilson Disease

被引：0

作者：

Khoo, Cheen ^{[1
]}

Hammond, Suzan M. ^{[1
]}

Sherrington, Sarah ^{[1
]}

Martins, Laura ^{[1
]}

Powles, Robert J. ^{[1
]}

Kennedy, Vicky ^{[1
]}

Guzman, Efrain ^{[1
]}

O'Connor, Deirdre ^{[1
]}

Mitrophanous, Kyriacos ^{[1
]}

Lad, Yatish ^{[1
]}

机构：

[1] Oxford Biomed, Oxford, England

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1140

引用

页码：546 / 546

页数：1

共 50 条

[31] Vector-based Vaccines for Cancer Therapy
Schlom, Jeffrey
Hodge, James W.
Tsang, Kwong-Yok
Palena, Claudia
Greiner, John W.
Madan, Ravi A.
Gulley, James L.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 100 - 100
[32] Construction and pproduction of lentiviral vectors for liver targeted gene therapy of Wilson disease.
Merle, U
Encke, J
Naldini, L
Stremmel, W
HEPATOLOGY, 2002, 36 (04) : 442A - 442A
[33] Host antibacterial defense of 6–10 Gy γ-irradiated mice subjected to lentiviral vector-based Gas5 gene therapy
Ichiaki Ito
Bradford D. Loucas
Sumihiro Suzuki
Makiko Kobayashi
Fujio Suzuki
Gene Therapy, 2023, 30 : 172 - 179
[34] Lentiviral vector-based vaccine against SIV infection and simian AIDS
Beignon, A.
Mollier, K.
Liard, C.
Munier, S.
Riviere, J.
Coutant, F.
Boulay, A.
Caleechurn, L.
Souque, P.
Bauche, C.
Charneau, P.
RETROVIROLOGY, 2009, 6
[35] Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
Coutant, Frederic
Frenkiel, Marie-Pascale
Despres, Philippe
Charneau, Pierre
PLOS ONE, 2008, 3 (12):
[36] Lentiviral vector gene therapy for Omenn Syndrome
Capo, V.
Castiello, M. C.
Draghici, E.
Maina, V.
Poliani, P. L.
Fontana, E.
Carrera, P.
van Til, N. P.
Wagemaker, G.
Bosticardo, M.
Villa, A.
HUMAN GENE THERAPY, 2015, 26 (10) : A54 - A54
[37] Lentiviral Vector Gene Therapy: Effective and Safe?
Persons, Derek A.
MOLECULAR THERAPY, 2010, 18 (05) : 861 - 862
[38] Onasemnogene abeparvovec AAV vector-based gene-replacement therapy Treatment of spinal muscular atrophy
Paton, D. M.
DRUGS OF THE FUTURE, 2019, 44 (08) : 625 - 633
[39] Efficient concentration of a lentiviral based gene therapy vector for systemic delivery
Huentelman, MJ
Katovich, MJ
Gelband, CH
Raizada, MK
FASEB JOURNAL, 2001, 15 (04): : A99 - A99
[40] Lentiviral vector induced insertional mutagenesis in gene therapy of hereditary liver disease
Rothe, M.
Rittelmeyer, I.
Brugman, M.
Iken, M.
Bock, M.
Schambach, A.
Manns, M. -P.
Baum, C.
Ott, M.
Modlich, U.
HUMAN GENE THERAPY, 2009, 20 (11) : 1511 - 1511

← 1 2 3 4 5 →